Why the study?
Despite declining complications with operator experience, serious and potentially fatal events such as device embolization can still occur after WATCHMAN deployment.
Highlights a rare but serious complication of WATCHMAN device embolization leading to catastrophic mitral regurgitation and the role of TEE in its identification and management.
WATCHMAN (Boston Scientific, Plymouth, MN, USA) is the most commonly utilized left atrial appendage occlusion device. Although increased operator experience has led to a significant decline in reported complications, serious and potentially fatal events can still occur. We present a case of WATCHMAN device embolization that was identified using transesophageal echocardiography shortly after device deployment, along with the subsequent management and retrieval of the device.
No takes yet. Share an insight, caveat, or question.
Jouryyeh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: